medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2014, Número 3

<< Anterior Siguiente >>

Rev Esp Med Quir 2014; 19 (3)


Plasma rico en plaquetas y tendinopatías

Villaseñor-Moreno JC, Sánchez-Ortiz ÁÓ, Herrera-Flores R

Idioma: Español
Referencias bibliográficas: 57
Paginas: 316-325
Archivo PDF: 495.08 Kb.


RESUMEN

La tendinopatía es una afección común en los pacientes que acuden a los servicios de medicina física y rehabilitación. Generalmente es tratada con antiinflamatorios no esteroides, paracetamol, infiltraciones con esteroides y terapia física. Sin embargo, algunos pacientes con “tendinopatía crónica“ son refractarios al tratamiento. El plasma rico en plaquetas es una opción terapéutica que ha demostrado ser una herramienta efectiva para el tratamiento de esta afección.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Halpern BC, Chaudhury S, Rodeo SA. The role of plateletrich plasma in inducing musculoskeletal tissue healing. HSS J 2012;8(2):137-45.

  2. Bava ED, Barber FA. Platelet-rich plasma products in sports medicine. Phys Sportsmed 2011;39(3):94-9.

  3. Albanese A, Licata ME, Polizzi B, Campisi G. Plateletrich plasma (PRP) in dental and oral surgery: from the wound healing to bone regeneration. Immun Ageing 2013;10(1):23.

  4. Middleton KK, Barro V, Muller B, Terada S, Fu FH. Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries. Iowa Orthop J 2012;32:150-63.

  5. Sunitha Raja V, Munirathnam Naidu E. Platelet-rich fibrin: evolution of a second-generation platelet concentrate. Indian J Dent Res 2008;19(1):42-6.

  6. Gentile P, Orlandi A, Scioli MG, Di Pasquali C, Bocchini I, Cervelli V. Concise review: adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical implications for tissue engineering therapies in regenerative surgery. Stem Cells Transl Med 2012;1(3):230-6.

  7. Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010;83(1):1-9.

  8. Hoksrud AF, Bahr R. Injectable agents derived from or targeting vascularity: has clinical acceptance in managing tendon disorders superseded scientific evidence? J Musculoskelet Neuronal Interact 2011;11(2):174-84.

  9. Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat 2007;16(4):156-65.

  10. Zhang N WY, Qian SJ, Teng C, Chen S, Li H. Research progress in the mechanism of effect of PRP in bone deficiency healing. Scientific World Journal 2013;4.

  11. Akhundov K, Pietramaggiori G, Waselle L, Darwiche S, Guerid S SC, Hirt-Burri N, et al. Development of a costeffective method for platelet-rich plasma (PRP) preparation for topical wound healing. Ann Burns Fire Disasters 2012;25(4):207-13.

  12. Skjong CC, Meininger AK, Ho SS. Tendinopathy treatment: where is the evidence? Clin Sports Med 2012;31(2):329-50.

  13. Maniscalco P, Gambera D, Lunati A, Vox G, Fossombroni V, Beretta R, et al. The “Cascade” membrane: a new PRP device for tendon ruptures. Description and case report on rotator cuff tendon. Acta Biomed 2008;79(3):223-6.

  14. Beck J, Evans D, Tonino PM, Yong S, Callaci JJ. The biomechanical and histologic effects of platelet-rich plasma on rat rotator cuff repairs. Am J Sports Med 2012;40(9):2037- 44.

  15. Cheung EV, Silverio L, Sperling JW. Strategies in biologic augmentation of rotator cuff repair: a review. Clin Orthop Relat Res 2010;468(6):1476-84.

  16. Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Corrêa do Amaral RJ, Granjeiro JM, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 2013;4(3):67.

  17. Nguyen RT, Borg-Stein J, McInnis K. Applications of plateletrich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011;3:226-50.

  18. Ferrero G, Fabbro E, Orlandi D, Martini C, Lacelli F, Serafini G, et al. Ultrasound-guided injection of platelet-rich plasma in chronic Achilles and patellar tendinopathy. J Ultrasound 2012;4:260-6.

  19. Sommeling CE, Heyneman A, Hoeksema H, Verbelen J, Stillaert FB, S. M. The use of platelet-rich plasma in plastic surgery: a systematic review. J Plast Reconstr Aesthet Surg 2013;3:301-11.

  20. Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol 2012;7:1185-95.

  21. Prochazka V, Klosova H, Stetinsky J, Gumulec J, Vitkova K, Salounova D, et al. Addition of platelet concentrate to Dermo-Epidermal Skin Graft in deep burn trauma reduces scarring and need for revision surgeries. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013;3.

  22. Eduardo Anitua, Roberto Prado, Mikel Sánchez, Gorka Orive. Platelet-Rich Plasma: Preparation and Formulation. Operative Techniques in Orthopaedics 2012;22(1):25-32.

  23. Anitua E, Zalduendo MM, Alkhraisat MH, Orive G. Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors. Ann Anat 2013;5(5):461-6.

  24. Omer Mei-Dan, Michael R. Carmont. Novel Applications of Platelet-Rich Plasma Technology in Musculoskeletal Medicine and Surgery. Operative Techniques in Orthopaedics 2012;22(2):56-63.

  25. Amy S. Wasterlain, Hillary J. Braun, Jason L. Dragoo. Contents and Formulations of Platelet-Rich Plasma. Operative Techniques in Orthopaedics 2012;22(1):33-42.

  26. Zhu Y, Yuan M, Meng HY, Wang AY, Guo QY, Wang Y, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage 2013;(11):1627-37.

  27. Lee JW, Kwon OH, Kim TK, Cho YK, Choi KY, Chung HY, et al. Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg 2013;(5):530-5.

  28. Mishra A, Woodall J Jr, Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sport Med 2009;(1): 113-25.

  29. Simone Cerciello, Knut Beitzel, Nathan Howlett, Ryan P. Russell, John Apostolakos, Mary Beth McCarthy, et al. The Use of Platelet-Rich Plasma Preparations in the Treatment of Musculoskeletal Injuries in Orthopaedic Sports Medicine. Operative Techniques in Orthopaedics 2013;23(2):69-74.

  30. Sampson S, Gerhardt M, B. M. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 2008;(3-4):165-74.

  31. Sarah L. Franklin, Nicola Maffuli, Mark E. Morrey. The Use of Platelet-Rich Plasma for Percutaneous Treatment of Tendinopathies. Operative Techniques in Orthopaedics 2013;23(2):63-8.

  32. Andre F. Steinert, Kellie K. Middleton, Paulo H. Araujo, Freddie H. Fu. Platelet-Rich Plasma in Orthopaedic Surgery and Sports Medicine: Pearls, Pitfalls, and New Trends in Research. Operative Techniques in Orthopaedics 2012;22(2).

  33. Maffulli N, Khan KM, Puddu G. Overuse tendon conditions: time to change a confusing terminology. Arthroscopy 1998;14(8):840-3.

  34. Maffulli N, Wong J, Almekinders LC. Types and epidemiology of tendinopathy. Clin Sports Med 2003;22(4):675-92.

  35. Fukuda H, Hamada K, Yamanaka K. Pathology and pathogenesis of bursal-side rotator cuff tears viewed from en bloc histologic sections. Clin Orthop Relat Res 1990;254:75-80.

  36. H. A. The chronic painful Achilles and patellar tendon: research on basic biology and treatment. Scand J Med Sci Sports 2005;15(4):252-9.

  37. Seitz AL, McClure PW, Finucane S, Boardman ND 3rd, Michener LA. Mechanisms of rotator cuff tendinopathy: intrinsic, extrinsic, or both? Clin Biomech 2011;26(1):1-12.

  38. Cook JL, Khan KM, Kiss ZS, Coleman BD, L. G. Asymptomatic hypoechoic regions on patellar tendon ultrasound: A 4-year clinical and ultrasound followup of 46 tendons. Scand J Med Sci Sports 2001;11(6):321-7.

  39. Gärdin A, Brismar TB, Movin T, Shalabi A. Dynamic contrast enhanced magnetic resonance imaging in chronic Achilles tendinosis. BMC Med Imaging. 2013;13(1):39.

  40. Bell R, Li J, Gorski DJ, Bartels AK, Shewman EF, Wysocki RW, et al. Controlled treadmill exercise eliminates chondroid deposits and restores tensile properties in a new murine tendinopathy model. J Biomech 2013;46(3):498-505.

  41. Mautner K, Colberg RE, Malanga G, Borg-Stein JP, Harmon KG, Dharamsi AS, et al. Outcomes after ultrasound-guided platelet-rich plasma injections for chronic tendinopathy: a multicenter, retrospective review. PM R 2013;5(3):169-75.

  42. Morrey ME, Dean BJF, Carr AJ, Morrey BF. Tendinopathy: Same Disease Different Results-Why? Oper Tech Orthop 2013;23:39-49.

  43. Lake JE, Ishikawa SN. Conservative treatment of Achilles tendinopathy: emerging techniques. Foot Ankle Clin 2009;14(4):663-74.

  44. Fırat T, Türker T. Is the long sarcomere length responsible for non-traumatic supraspinatus tendinopathy? Potential novel pathophysiology and implications for physiotherapy. Pathophysiolog 2013;19(3):179-83.

  45. Grau S, Maiwald C, Krauss I, Axmann D, Janssen P, T. H. What are causes and treatment strategies for patellar-tendinopathy in female runners? J Biomech 2008;41(9):2042-6.

  46. Abrahams Y, Laguette MJ, Prince S, M. C. Polymorphisms within the COL5A1 3’-UTR that alters mRNA structure and the MIR608 gene are associated with Achilles tendinopathy. Ann Hum Genet 2013;77(3):204-14.

  47. September AV, Cook J, Handley CJ, van der Merwe L, Schwellnus MP, Collins M. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br J Sports Med 2009;43(5):357-65.

  48. Bishay V, Gallo RA. The evaluation and treatment of rotator cuff pathology. Prim Care 2013;40(4):889-910.

  49. Rolf C, Movin T. Etiology, histopathology, and outcome of surgery in achillodynia. Foot Ankle Int 1997;18(9):565-9.

  50. Alvarez-Nemegyei J, Peláez-Ballestas I, Rodríguez-Amado J, Sanin LH, Garcia-Garcia C, Garza-Elizondo MA, et al. Prevalence of rheumatic regional pain syndromes in adults from Mexico: a community survey using COPCORD for screening and syndrome-specific diagnostic criteria. J Rheumatol Suppl 2011;86:15-20.

  51. Kaux JF, JM. C. Platelet-rich plasma application in the management of chronic tendinopathies. Acta Orthop Belg 2013;79(1):10-5.

  52. Sadoghi P, Lohberger B, Aigner B, Kaltenegger H, Friesenbichler J, Wolf M, et al. Effect of platelet-rich plasma on the biologic activity of the human rotator-cuff fibroblasts: A controlled in vitro study. J Orthop Res 2013;31(8):1249- 53.

  53. Via AG, De Cupis M, Spoliti M, Oliva F. Clinical and biological aspects of rotator cuff tears. Muscles Ligaments Tendons 2013;3(2):70-9.

  54. Mishra A, Randelli P, Barr C, Talamonti T, Ragone V, Cabitza P. Platelet-rich plasma and the upper extremity. Hand Clin 2012;28(4):481-91.

  55. Kesikburun S, Tan AK, Yilmaz B, Yasar E, Yazicioglu K. Platelet-Rich Plasma Injections in the Treatment of Chronic Rotator Cuff Tendinopathy: A Randomized Controlled Trial With 1-Year Follow-up. Am J Sports Med 2013;41(11):2609- 16.

  56. Castricini R, Longo UG, De Benedetto M, Panfoli N, Pirani P, Zini R, et al. Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med 2011;39(2):258-65.

  57. Zhang Q, Ge H, Zhou J, Cheng B. Are platelet-rich products necessary during the arthroscopic repair of full-thickness rotator cuff tears: a meta-analysis. PLoS One 2013;8(7).




2020     |     www.medigraphic.com